Product NewsGemacBio announces the successful conclusion of Phase IIa clinical trials for its new molecule designed to treat multiple sclerosis
Product NewsSigma Launches Human Plasma Depletion Technology for Proteomics and Human Disease Biomarker Discovery
Product NewsElectrophoretic fingerprinting of HIV/AIDS virus – another first for the Malvern Zetasizer Nano
Product NewsSYMPHOGEN’S SUCCESS IN MANUFACTURING CONSISTENT BATCHES OF POLYCLONAL ANTIBODIES FOR CLINICAL TRIALS ATTRACTS NEW USD 25 MILLION INVESTMENT
